Clinitech Laboratory opened lower at -, compared with its previous close of ₹30.00. In the last trading session on 12 Nov 2026, the stock traded between - and -, with an average traded price of -. It showed a sideways intraday trend.
An investment of ₹10,000 made 3 years ago in Clinitech Laboratory is now worth
₹ 2,484.00
Resulting in a loss of
₹ 7,516.00 (75.16%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.00 (+0.00%)
Day High
-
Day Low
-
Day Open
-
Prev Close
₹30.00
Volume
-
Value Traded
-
1W Return
0.00%
1M Return
-10.85%
3M Return
-25.00%
6M Return
-19.57%
1Y Return
-31.82%
Market Cap (₹ Cr.)
7
PE Ratio
16.50
PB Ratio
0.74
Dividend Yield
-
ROE
4.48%
ROCE
6.62%
Book Value (₹)
40.52
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
0.00%
6 Weeks
-
1 Month
-10.85%
3 Months
-25.00%
9 Months
-36.37%
Clinitech Lab certifies RPT exemption for H1FY26
Certified non-applicability of Regulation 23 for H1FY26. Exemption granted due to BSE SME platform listing status. Paid-up equity capital stood at ₹2.28 crore in FY26. Net worth increased to ₹9.25 crore in FY26 from ₹8.83 crore in FY25.
21 days agoClinitech Laboratory shareholders approve all AGM resolutions unanimously
All three AGM resolutions passed with 100% support from valid voters. Ordinary resolutions received 1,613,900 votes in favour. Special resolution on Section 185 transactions got 206,700 votes in favour. Three members' votes totaling 1,407,200 were declared invalid for the special resolution. Eight shareholders participated via Video Conferencing out of 271 on record.
1mo agoClinitech Laboratory fixes Sept 24 for 16th AGM, outlines e-voting
Clinitech Laboratory schedules 16th AGM for September 24, 2026. Meeting to be held via video conferencing at 11:30 am. E-voting window opens September 21 and closes September 23. Book closure period is from September 18 to September 24.
2mo agoClinitech FY26 net profit rises 7% to ₹42.25 lakh
Clinitech Laboratory reported a 7% rise in FY26 net profit to ₹42.25 lakh, supported by a 15% revenue increase to ₹947.50 lakh. The Board approved the audited results on May 28, 2026, with statutory auditors issuing an unmodified opinion.
5mo agoClinitech Laboratory Limited Files Undertaking for Non-Applicability of Related Party Transactions for FY26
Clinitech Laboratory Limited has filed an undertaking with BSE Limited confirming that Related Party Transactions regulations under SEBI LODR are not applicable for FY26. The SME-listed company remains below threshold limits, qualifying for exemption under Regulation 15. The undertaking was signed by Chairman and Managing Director Jagdish Umakant Nayak on April 22, 2026, ensuring regulatory compliance and transparency.
6mo agoClinitech Laboratory Confirms Exemption from Annual Secretarial Compliance Report for FY26
Clinitech Laboratory Limited has notified BSE Limited of its exemption from the Annual Secretarial Compliance Report for FY26 under SEBI LODR Regulation 15(2). As an SME-listed entity, the company is exempt from various corporate governance provisions including Regulation 24A. The undertaking was signed by Chairman and Managing Director Jagdish Umakant Nayak on April 15, 2026.
7mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹8,589.00 | +0.87% | ₹1,23,496.64 | 52.40 | +14.55% | |
| ₹946.00 | -0.03% | ₹92,075.15 | 66.60 | -14.28% | |
| ₹685.90 | +1.39% | ₹90,221.72 | 98.20 | +16.25% | |
| ₹720.10 | -2.15% | ₹62,769.13 | 113.80 | +5.69% | |
| ₹763.10 | +0.41% | ₹57,610.86 | 54.00 | -21.28% | |
| ₹1,447.20 | +0.52% | ₹38,911.12 | 63.10 | +23.29% | |
| ₹1,859.10 | +1.03% | ₹37,992.72 | 43.70 | +5.68% | |
| ₹1,981.50 | -1.36% | ₹33,259.24 | 57.30 | +28.64% | |
| ₹729.85 | +0.35% | ₹30,654.17 | 155.10 | +6.18% | |
| ₹446.95 | -0.19% | ₹18,041.99 | 97.10 | -32.67% | |
| ₹554.00 | +0.50% | ₹17,563.25 | 85.10 | +8.39% | |
| ₹670.00 | +0.59% | ₹16,144.77 | 39.00 | +31.68% |
An investment of ₹10,000 made 3 years ago in Clinitech Laboratory is now worth
₹ 2,484.00
Resulting in a loss of
₹ 7,516.00 (75.16%)
Note: Past profits do not guarantee future returns.
